180 Degree Capital Corp.

180 Degree Capital Corp.

$3.73
0.06 (1.63%)
NASDAQ Global Market
USD, US
Asset Management

180 Degree Capital Corp. (TURN) Q3 2020 Earnings Call Transcript

Published at 2020-11-19 15:29:07
Daniel Wolfe
Good morning and welcome to 180 Degree Capital Corp.’s Third Quarter 2020 Financial Results Update Call. This is Daniel Wolfe, President and Portfolio Manager of 180 Degree Capital. Kevin Rendino, our Chief Executive Officer and Portfolio Manager, and I would like to welcome you to this call this morning. All participants are currently in a listen-only mode. Following our prepared remarks, we will open the line to questions. I would like to remind participants that this call is being recorded, and that we will be referring to a slide deck that we have posted on our Investor Relations website at ir.180degreecapital.com under Financial Results.
Kevin Rendino
Good morning, Dan. You can hear me, right?
Daniel Wolfe
Yes, I can.
Kevin Rendino
Okay, great. We're in separate places today. Good morning, everyone. I hope everyone is safe and healthy, and here's hoping we're in the final leg of what has been an incredibly depressing pandemic in a difficult 2020. Turning to Slide 2, a summary of our third quarter, one in which our NAV climbed 7.4% on the backs of a 25% gain from our public stock picking. This was offset by a 10% decline for write-downs in our private portfolio. The public market performance was led by Maven, Potbelly, Lantronix and Quantum, with only one negative in the quarter, and that would be Sonim. Our private portfolio decline was led by 3 names: Essential, ORIG3N and Lodo. We have a separately managed account that's been up and running for a few months now and had a similar run of great performance in the quarter. Let's move to the next slide. On Slide 3, you'll see, all in all, we had a massive snap back in our NAV over the last 2 quarters, rising to $2.90 at quarter end. This book value is very close to our high that we established just 3 quarters ago. Let's move to the next slide. Slide 4 really matters to me. At the end of the day, judge us as much for our equity performance, but also judge us for this slide. We've nearly tripled the amount of cash and liquid securities we have on our balance sheet. The higher this per share amount goes, the higher the floor should go for our share price. We're finally beginning to build some scale at 180. The law of averages say, it may be easier to take our book value from $2.90 to $6, starting with $55 million of cash or $1.78 per share, then it has been taking our book value from the low $2s to the almost $3 level that it is today, given we started this exercise with only $17 million of cash or so and $0.64 per share.
Daniel Wolfe
Sounds good. Thanks, Kevin. Please turn to Slide 20. This slide lists our 10 legacy privately held holdings by value as of the end of the quarter. For the quarter, as Kevin mentioned, our private portfolio decreased in value by approximately $4.3 million or $0.14 a share. The largest decreases were in Essential Health Systems, ORIG3N and Lodo. These declines were due to specific events in the portfolio company. We are under confidentiality with these portfolio companies, so it's difficult to go into too many specifics there. But there were also no material increases in value in the private portfolio this quarter -- in this quarter. In almost every shareholder letter and update call, we state that while we desire to shepherd our existing private portfolio to exits or to explore opportunities to sell our positions in those companies, we have the luxury of being able to sell our private holdings when we believe it makes sense for shareholders rather than being forced to do so to survive. The remaking of our business and the significant cash and securities of public portfolio companies that we have built, mean that we don't have to sell anything unless we feel that it is the right thing to do for shareholders. Any decision to sell our private portfolio would be based on a variety of factors and not limited to just the sale price. Selling our private portfolio would allow us to focus all of our time and efforts on our public investment strategy. We would also reduce certain operating expenses that are incurred solely because of the private portfolio. As Kevin said earlier, since the start of 180, our private portfolio has reduced NAV by $0.27 and for our public investing strategy has increased NAV by $1.30. It is important to note that future results may be materially different than prior results. That said, we remain interested to provide -- to monetize this private portfolio. Please turn to Slide 21. As we have noted in previous letters, we have dramatically reduced our cost structure under our new strategy. In 2016, before our funds change, investment focus and management team, our operating expenses, excluding stock-based compensation and interest on outstanding debt that we had at the time, averaged approximately $1.3 million per quarter. For Q3 2020, our operating expenses equaled approximately $790,000. I remind shareholders that our Q1 2020 expenses included a reversal of the deferred portion of the 2019 bonus of approximately $317,000. This deferred portion of the 2019 bonus has yet to be reinstituted as of the end of Q3 2020, and it will ultimately be the decision of the Comp Committee of our Board of Directors at the end of the year on whether or not that is reinstituted and also any bonuses for 2020. Please turn to Slide 22 and 23. We continue to anticipate that reductions in our operating expenses as a percentage of net assets will be based on growth in our net assets rather than further reductions in our expenses. The positive events in Q3 2020 discussed previously if they hold throughout the quarter -- the year, will help reduce these expense ratios as of the next quarter and in future years. We remain committed to treating every dollar of shareholder money with the utmost care and consideration. As we continue to say and will repeat all the time, it is much easier to grow NAV when the expense hurdle rate is where it is today. I'll turn it back over to Kevin.
Kevin Rendino
Thanks, Daniel. The last couple of slides are just -- are some of the parts, which we show for you every quarter. At the end of the day, the remaining portfolio of value, not being ascribed to our public and cash and liquid securities, is about $0.15 a share if you give us full credit for our cash and liquid securities. That means the market is paying $4 million for $35 million in assets. That's the way it shakes out. It makes no sense to me. I've said that before. We will have wins in the private portfolio. We've had -- we've showed you where some of the wins are, companies like Petra and Mersana over the last couple of years, sales like HZO. We'll have them again. But $4 million, by the way, is less than the net present value of the cash flows that we hopefully can expect to receive from our investment in Petra that was taken over last quarter and trades at nearly -- $4 million trades at about 30% of the value we have for 1 security, which happens to be AgBiome. And I know there's a lot of folks around the private equity markets and the VC markets that would love to own AgBiome. So we feel okay about the private portfolio. We'll continue to run our strategy around creating performance from what we can control on a daily basis, which is our public portfolio. And I certainly think that some of the charts show that our equity is fairly inexpensive relative to the book value that we actually have, which is $2.90. So why don't we stop there, Daniel, and then open it up for Q&A. A - Daniel Wolfe: Sounds great. Whitney. Please go ahead.
Unidentified Analyst
I have a sort of a broad question -- well, actually, a specific question about D-Wave and AgBiome. We have, in the case of both of these end markets, just extremely full pricing in the case of computing and electronics and so forth, wild valuations as Kevin has remarked in that space. In the agricultural business, I mean, 4 years ago, I was a kid hauling grain between Central Kentucky and Illinois and Ohio. And we've almost got prices where we were then, which was a period of a bottle, partially from bunker hot driving soybeans to almost $20 a bushel. Regardless of all that history, I don't -- I can't recall a time when agricultural -- raw agricultural markets have enjoyed such high pricing. So my question is, what is D-Wave waiting on to do some sort of structure or possibly even going public? And what is -- what do you think are the structural impediments for AgBiome to receive some sort of significant event possibly going public, possibly being taken over by someone. And I guess, lastly, is sort of a segue. Novozymes is apparently a partner in AgBiome, Novozymes have been around for a long time and had an incredible track record. What -- I mean, that would seem to me to be a logical exit strategy for AgBiome to sell to Novozymes. So I guess it's sort of a bushel full of questions that probably you guys can easily address, but in any event, please share whatever light you can on those 2 subjects.
Kevin Rendino
Daniel, let me try and take this one and then add on, if you don't mind.
Daniel Wolfe
Certainly.
Kevin Rendino
We ask the same questions, Whitney. If I had controlling stakes in companies, like these, there's a forcing mechanism, which we don't have in the private markets, which we do have in the public markets. So we ask the same questions. Look, I got here in 2017. D-Wave started in 1999. Part of D-Wave's problems was it was answering questions from an AI perspective, and the questions hadn't even been asked before. So their technology seems to be way ahead of its time. But from a commercial perspective, they were -- they've had a very difficult time of getting their -- basically their technology into the hands of the people that were going to use it because I think they were way ahead of their time. And over the years, they've had to raise money and more money and more money and more money to fund the engineers to build the technology that they've built. And as such, you end up getting diluted over time because every third quarter, it seems like you run out of the $50 million that you raised. So D-Wave has been a source of bitter disappointment for all of us. And you've seen that valuation get shredded in the last 2 years because the company was run by an ineffective management team that could not make their technology commercial. So that's one. Now I agree with you that there's still great technology there, and there's still a place for them. And again, Daniel, you can add on to this. With regards to AgBiome, I think they like being private, the like being private until they find how difficult it is to raise money in the private markets forever. They've actually built a nice business. And the one thing -- and I agree with you, Whitney. Now should be the time. But the one thing about AgBiome that's different from D-Wave, we've gotten paid on AgBiome. If you go back and look at our book value in AgBiome, while it's not public cash for us to go get, our valuation has gone from the low, I don't know, $2 million or $3 million, $4 million to $13 million as a result that they've been able to raise capital, in the private markets at valuation levels that were sort of as high or higher than the previous round. And so that has been a successful investment over time. But if they overstay their welcome in the private markets and can't build scale in their businesses, they'll suffer the same fate as every other private business that hangs around too long and doesn't find the right window to monetize itself. Now, I think those guys are super smart, the board is super smart. I didn't -- Daniel knows this. I did not feel that way about D-Wave's Board nor the former CEO of D-Wave nor the former CFO of D-Wave. I feel differently about AgBiome. But we'll see, like the proof is in the pudding. And to me, it seems like there's a great appetite in market for something that AgBiome and D-Wave do, but it's up to them to do it. So there's only so much we can do Whitney in terms of voicing our hope and desire, and that really is the truth. Again, we don't own controlling stakes in these companies and, therefore, can't force them to do anything, which is part of the frustration in the private portfolio. Daniel, is there anything else you wanted to add? I don't know if I did a good job of summing that up.
Daniel Wolfe
I think -- no. I think you summed up perfectly. The only thing I'd add is, everything Kevin just said is exactly why we needed to make the change in the business that was made.
Unidentified Analyst
Yes. No, I totally get all that. I actually listened to one of the D-Wave guys speaking, I don't know, a couple of months ago, something like that. I can't remember what his position was, but the impression that I walked away from was this, this was totally wrapped up in math and he's not running a business.
Kevin Rendino
There you go. You summed it up.
Unidentified Analyst
And -- So anyhow, I totally get it, and these are legacy assets, and we just got to do whatever we can do to keep plugging away at all of it. And lastly, I just want to thank you both for everything that you're doing to advance the calls. That's all I've got.
Kevin Rendino
Appreciate that, Whitney. Yes. Well, I should give you the CEO's phone number at both places. You can lob in your views there because we certainly -- we share them.
Daniel Wolfe
Well, absolutely.
Unidentified Analyst
I'd love to think that I could make a difference. But if you think I can make a difference, I'll call them, I'm not afraid to talk to anybody.
Kevin Rendino
Thanks, bud, I appreciate it.
Daniel Wolfe
Brian, go ahead.
Unidentified Analyst
Are you able to hear me?
Daniel Wolfe
We can.
Kevin Rendino
We can.
Unidentified Analyst
High level, there's -- the investment de jure of 2020 seems to be SPACs. Do you -- are you guys aware of any SPAC interest in any of the private companies? I mean, not looking for anything specific. And then if so, do you know what the hang up has been for any of those that have received possible interest from SPACs?
Kevin Rendino
If they had interest in SPACs, they'd be SPACs, they're not. So you could assume either there's no interest or they're working on becoming SPACs. And if they were, I certainly couldn't say that in a public manner because that's certainly the information that I would have that I couldn't share. Many of our companies are small. Some of these SPACs that are coming out are hundreds of millions of dollars. So that is certainly a path in an avenue that has been created in the last couple of years. What is there 130 of them out there? It's another alternative way to become public without having to go through the rigors of the normal IPO market. We do our best to shed that light for the companies that we own and let them know. I mean, that's our area of expertise is sharing Wall Street wisdom. Daniel does a good job of sharing that wisdom with the companies that we own, including a couple that we've already talked to. At the end of the day, as I said earlier, we don't have controlling stakes, and we can't force. We can only recommend the paths for them. So it's certainly a path that exists that didn't exist. That should be helpful. But until they become SPACs, they're still private companies. And all these guys can talk, talk, talk all they want. It's a matter of executing and walking the walk. So we've shared that -- your views about how to become public with most of our companies, and we'll continue to do some. So I think it's a good thought.
Unidentified Analyst
Great. I appreciate your thoughts there. That's all for me. Thanks for another good quarter, keep up the good work.
Brandon Goyette
Brandon Goyette from Delta Investment Group. I noticed you guys are carrying about $20,000 a quarter on broker-dealer expenses. What business is that supporting? And are you getting a decent return on that?
Kevin Rendino
Daniel?
Daniel Wolfe
Yes. So we formed the broker-dealer as a way for us to be able to compensate individuals that are within the firm, particularly Rob Bigelow, who's helping with fund development and raising additional capital. I think we've talked about earlier that -- and it's in the shareholder letters, it isn't an area that we're interested in doing. That's also why we registered as an RIA to able manage that external capital. And what I would say is it's a focus of our efforts, and we'll continue to drive forward on that. And our expectation currently is that it will be a good investment as we look to bring on additional capital to manage.
Kevin Rendino
So we have -- we generated a $25 million win from a public company's pension fund. That would not have been possible had we not had the performance numbers that we've had and the relationships that we're making with outside sources of capital. If we can't raise money above and beyond that, we think it's already paid for itself. So that's number one. Number two, if we can't raise money or we feel that we have enough equity and capital on our own balance sheet, and therefore, don't have an interest in raising outside capital, we'll shut the broker-dealer down. It's a "how do we pay people to generate revenue for us" mechanism. That's all it is, which is what we said from day 1.
Daniel Wolfe
Zach, go ahead.
Zach Liggett
Nice job on your continued work here. Two questions, if I can. First off, on Sonim and the decision to become a Board observer. I guess I'm just curious on the general philosophy on why you choose to do that versus sort of just informal dialogue with management? And does becoming an observer handicap your ability to transact in the shares? Clearly, the stock got whacked pretty good here. And I'm just curious if by being an observer, you lose that flexibility to add to the position.
Kevin Rendino
We do lose the flexibility, which is why we say we're value investors first, constructive activists second. We prefer not to be on any boards if we don't have to be. It's a lot of work, as you know. You do put yourself in a position where you lose the flexibility to trade in and out of names the way you would if you haven't filed or you're not a Board observer or a member of the Board. But we go on boards when we want to enact change, and we want to have a say in the final outcome of the business and where we think we can help. And so in the case of Sonim, it's very specific, Synacor as well. We went on with an agenda. How do we create value for our shareholders in the shortest period of time and with the most maximum percentage of value creation for shareholders? We -- sometimes we're asked to go on boards. And sometimes we force our way on boards. But every time that we've been on a Board, it's been collaborative and collegial and an agreement that we see eye-to-eye with what needs to get done, and we're willing to roll up our sleeves to get it done. So that's why we do it. We want a final say in the inevitable outcome of how a business is going to be run. That means -- that can mean a lot of things. That can mean changing out the whole Board. It could be changing out the entire management team. it Could be selling the company I mean it -- I don't -- it could be a lot of things. But we want final say or more say in how -- we want to vote. That's the bottom line. And when you take our big -- the big stakes that we have, our vote -- our stakes carry with it a very large vote from a shareholder perspective, but it enables us to get the actual votes that matter, which are board votes. So that's kind of why we do it. We really don't want to do it every single time. I prefer buying Turtle Beach and watching it go from $4 to $16 in 42 days. Or I prefer watching Adesto go from $2 to $8, selling it, going back to $2, buying it and selling it at $8 again where we're not on the Board. And we have that flexibility. But when you don't believe in how businesses are running themselves from either a governance perspective or a management perspective, that's when you get involved more often. Potbelly is -- we really admire the CEO and the COO, I mean, really admire them. It's a restaurant company in the middle of a pandemic, sorry to mention the word again, where cases are spiking. And the company is going to have a couple of issues with comps in the next 2 months. We know that. But you know what, that business is in the hands of managers that get it. Management is everything to us. And when we find managers that we like, we let them go do their own thing, and we don't need to be involved. In the cases where we are involved, it's because we feel we need to be involved. It's because something is wrong at the top, and something needs to be changed from the top. So that's kind of -- I don't know, it's more philosophical than anything else. We -- this is not our day jobs. I don't expect to be on the Sonim Board 3 years from now. I don't expect to be on the Synacor Board 3 years from now. When we joined TheStreet Board in November of '17, we didn't expect to be on TheStreet Board in 3 years from that moment, and we were only on for 1.5 years, but you know what, we were able to help the business sell itself. So that's kind of why you do what you do. And if you limit your flexibility in terms of selling, I don't care because we're not doing this, as I said earlier, for instantaneous performance or for quarterly performance, we're doing this to have home run investments in the names that we choose to invest in. And if Sonim goes from $0.80 to $0.40, honestly, I don't care. If we buy it at $0.75, we hope to make money from $0.75. If we buy Synacor at $1.20, we hope that it goes to $2. It's things like that. It's not about what these stocks do on a quarterly basis. So anyway, I'm sorry, it was a long-winded soapbox, but that is how we think about it from a philosophical perspective.
Zach Liggett
Yes, I understand. I mean, it's -- there's art on that and I was just -- we saw -- I think it was last quarter, you talked about management being someone you knew. And I just -- I was kind of surprised to see you guys join as an observer rather than sort of keep -- preserve that value to buy, to make more money in this name, so...
Kevin Rendino
Let's -- hang on -- just on that alone, they had an unbelievable second quarter. You saw the third quarter they reported. It was really disappointing. So that was a little unsettling to us. And then you're right, I do have a high level of respect for the CEO. I was a reference for him when he was hired last fall. So that's why I feel like it's time for us to help him roll up our sleeves and try and figure it out together rather than just sort of abandon him. It's -- we own 14% of that company. So -- and by the way, that was a Board that needed to be fixed. That wasn't -- it's not necessarily a CEO, and they need to be changed out. That board and the folks that left needed to leave. You saw the stock has gone from $13 to $1 for a reason before we got here. And so we believed in our heart of hearts that going on to the Board or becoming Board observers would help the forcing mechanism of changing out Board members that have overseen a collapse in the equity price, not since we've owned it. We haven't owned it until last quarter. So -- and they've already started to make changes. So we're happy about that. Sorry, go ahead.
Zach Liggett
No. Good color. I think that's what makes what you guys are doing quite interesting in your willingness to invest the time. My second question was you made a comment in the letter this quarter. And you've mentioned the discount on multiple occasions. But I'm curious, when you guys look at the universe of smaller closed-end funds and other kind of holding company structures, what level of discount do you think is appropriate? And the reason I ask is, I just wonder where -- at what point does your interest get so peaked that you'd be buying your own stock instead of taking cash and investing that directly in the portfolio companies?
Kevin Rendino
So the first thing is we -- if we thought the environment for investing had -- was going to have a return profile less than us buying back our stock. We've done this exercise. I can show you the exercise. If you e-mail me after this, I can literally show you the spreadsheet that we have, which shows if we bought back x amount of dollars, how much of that would accrete to our book value? And you'd be very surprised that it's not -- unless you're going to do tens and tens and tens of millions of dollars. It's not as accretive as you think it is. But I could show you that. Conversely, we go back into the market every single quarter and buy stock with our own money out of our own pockets. You've seen that. So we put our money where our mouth is. Buying back stock, the -- what we would have to do is lay that out against the opportunity to make, hopefully, 100% of your money in companies like Potbelly and Quantum and Maven from here. And that return profile is just -- it's not very attractive, buying back our stock. It's just not. So I don't know what to say, other than maybe I'll be the only shareholder in 5 years because I'll -- the management team will have bought back every share from every investor that doesn't want to own it, and that's fine by me. We'll take it private ourselves. I don't know. I don't think our equity price should trade at cash and have a $4 million value ascribed to our private portfolio when we do real marks and the marks say, the -- we've got $35 million worth of assets there. Maybe the exercise is sell the whole private portfolio. If we could do that, we would. We said that 1,000 times. We should debate, and I said in our letter, as any good management team should. We should debate share repurchase. We should debate dividends. We should debate M&A. We should debate all of it, and we will and we have. And we will continue to do so. I'm not here for any other reason than trying to win for you and all of us as shareholders, and that's the truth. And I certainly don't think our share price reflects any of the turnaround that this company has seen over the last 3 years, I think it's actually ridiculous. And so in 1.5 days, when the market opens up for our management team, again, we'll go pile back into the market and buy stock at $1.90 because it's down $0.07, even though our book value is $2.90. So I'll show you the chart, if you want, just e-mail me afterwards, honestly, but buying back stock makes no sense.
Daniel Wolfe
Yes. And Zach, the other thing that I would add to Kevin's comment is, it's also not as simple of an analysis in that once stock is bought back, it's gone, right? The money is gone. And so it's not just do we think that is a better investment today, but we can recycle -- I mean, I'm not telling you anything that isn't self-evident, but it's an important factor in the analysis, which is to recycle our capital, we have a substantial amount of loss carryforwards that allow us to shelter that capital, those gains from tax for the foreseeable future. And so it really comes down to if we -- it's not only just today, but it's also going forward in the future as we look to recycle that capital, is that a better investment than our stock where once it's repurchased, literally, that cash has gone and given the restrictions on issuance of shares versus closed end funds, it makes it difficult to get back.
Kevin Rendino
To me, it's about imploding -- it's like anything else. You should pay a higher -- you pay less discount for managers that do a good job for shareholders, and the company should have a wider discount for managers that do a terrible job from a performance perspective. I don't think our performance in our new strategy over the last years has been -- warrants having a valuation that's less than almost any other closed-end fund that we look at. I just don't. I get the private portfolio is there. Investors have a difficult time putting a value on it. I totally get it. I do. I'm not -- I've said that 1,000 times also. But I don't know. We show 100% returns over 3 years. It's pretty good. That should -- and we think the market should pay us close to 90% or 95% worst case, if the whole business was cash and liquid securities, just on our ability to generate returns for people. But that's not only for me to determine. That's for the market to determine and the market has determined we're worth $1.92 today, whatever. It is what it is. We'll -- as a board, we've got to solve for that over time.
Zach Liggett
Yes. And I totally understand on that. My last question is just on -- you guys are a very small team. Do you -- have you communicated anything about success contingency planning in this lovely pandemic world that we're in. What happens, God forbid, that there's illness. Do you guys have plans to -- is there a broader team that can -- an advisory board or anything that you fall back on, or do you have folks that are identified or a contingency plan if something were to happen?
Kevin Rendino
Something happens to me, nobody would care. Joking. No, as a Board, it's -- we -- of course, boards always have to look at succession and planning for worst-case scenarios, you'll see on our Board, our last 2 board members have discrete Wall Street experience. This has been discussed at a Board level. Look, if something happens to me, the Board is going to have to solve for that, and they'll have a plan for solving for that. Daniel, I don't know what else to answer. We don't have someone in waiting for me or for Daniel, who either has a job and is ready to quit his or her job and come here or standing on the sidelines, waiting for one of us to leave. I mean, that doesn't work, right, in any organization. So the only thing that we can do is I want this business to be around a lot longer than we're going to be here. Our Board knows that, and our Board has a mechanism for how to figure that out. Daniel, I don't know what else you wanted to add?
Daniel Wolfe
Yes. The only thing I'll just add to is we do have a robust business continuity plan. We've been all working remotely. No issues there. It really is just like any other company that's out there, we do have the plans in place that if anything were to happen, especially since we are a small team, we do have the policies, procedures and everything else ready to kick in right away, and the company wouldn't miss a beat. So it's -- we -- the company needs to -- as we learned from founder of the firm back in the day, Charlie Harris, he always established it as the company is the entity, and we are employees of the entity, and the company continues on and the same philosophy, as you heard from Kevin is here.
Kevin Rendino
Yes. Look, the cash is going to be here for the next person. If it's not me or if it's not Daniel. And the Board is going to have to bring in a competent portfolio manager who knows how to run money. And there's a lot of those. I left BlackRock once, and I knew that when I left, they'd replace me with somebody else because life goes on. And we're all replaceable. So -- and I don't think that's any different here. By the way, I'm not -- unless I missed out something. For the record, I'm not going anywhere unless somebody removes me.
Daniel Wolfe
Likewise here. Same here. The queue is empty. I think we've answered all the questions.
Kevin Rendino
Okay. Everyone, thank you so much for your time today. It's been a trying year for everybody, a weird year for sure. And I'm looking forward to having this year-end and getting to a place where we all start moving out of our homes and back to work and to some level of normalcy. I pray that is 2021. I'm hopeful that it is. I think the vaccines that were announced are -- the effectiveness is terrific. And getting that out for manufacturer is going to be the logistics, and the logistics around that is going to be the main issue between now and the next few months, and hopefully, we'll get there. And I'm just looking forward to this year ending. In the meantime, we've got a good, solid month and change to try and generate returns from you, and we'll try and do that. You all know that -- where we are, you can text, you can email, you can call us. We'd be happy to talk to you about anything that you want to talk about at any given point in time. Thank you for your time, and good luck investing. Thanks.
Daniel Wolfe
Thank you, everyone. You can now disconnect.